ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q3 2021 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT) Q3 2021 Earnings Conference Call November 04, 2021 05:00 PM ET Company Participants Rich Vincent - Chief Financial Officer James Breitmeyer - President & Chief Executive Officer Salim Yazji - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer and Company Carl Byrnes - Northland Capital Markets Shubhendu Sen Roy - Brookline Capital Management Presentation Operator Greetings. Welcome to the Oncternal Therapeutics, Inc. Q3 2021 Financial Results Call. At this time, all participants are in listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to our host, Rich Vincent, CFO. Thank you. You may begin. Rich Vincent Thank you, Ash. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q3 2021 Results - Earnings Call Transcript